About Mereo BioPharma Group plc American Depositary Shares
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Market Cap
$0.37B
Employees
33
Listed Since
April 24, 2018
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.mereobiopharma.comPhone
4403330237300
Headquarters
ONE CAVENDISH PLACE
LONDON, X0 W1G0QF
CIK
0001719714